Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
Authors
Keywords
Cancer immunotherapy, Tumor microenvironment, Biomarkers, Baseline immunity, Immune checkpoint inhibitors
Journal
Journal for ImmunoTherapy of Cancer
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-12
DOI
10.1186/s40425-017-0243-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The FCGR3A polymorphism predicts the response to rituximab-based therapy in patients with non-Hodgkin lymphoma: a meta-analysis
- (2016) Duo Liu et al. ANNALS OF HEMATOLOGY
- Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
- (2016) Susanna Mandruzzato et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
- (2016) Bernhard Mlecnik et al. IMMUNITY
- Additional Support for the Introduction of Immune Cell Quantification in Colorectal Cancer Classification
- (2016) Robert L. Ferris et al. JNCI-Journal of the National Cancer Institute
- Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
- (2016) Alena Gros et al. NATURE MEDICINE
- Noninvasive Transcutaneous Vagus Nerve Stimulation Decreases Whole Blood Culture-Derived Cytokines and Chemokines: A Randomized, Blinded, Healthy Control Pilot Trial
- (2016) Imanuel Lerman et al. NEUROMODULATION
- Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
- (2016) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- NLRC5/MHC class I transactivator is a target for immune evasion in cancer
- (2016) Sayuri Yoshihama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
- (2016) R. D. Dorand et al. SCIENCE
- The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis
- (2016) Bernhard Mlecnik et al. Science Translational Medicine
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- Additional Support for the Introduction of Immune Cell Quantification in Colorectal Cancer Classification
- (2016) Robert L. Ferris et al. JNCI-Journal of the National Cancer Institute
- Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy
- (2016) B. Farsaci et al. Cancer Immunology Research
- Immune monitoring technology primer: immunoprofiling of antigen-stimulated blood
- (2016) Laura Rosa Brunet et al. Journal for ImmunoTherapy of Cancer
- Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity
- (2016) Gregory N. Dietsch et al. PLoS One
- Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer†
- (2015) C. Lim et al. ANNALS OF ONCOLOGY
- FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
- (2015) Rony Dahan et al. CANCER CELL
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Recent developments and future challenges in immune checkpoint inhibitory cancer treatment
- (2015) Bas D. Koster et al. CURRENT OPINION IN ONCOLOGY
- Recent developments in multiplexing techniques for immunohistochemistry
- (2015) Angela R Dixon et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Tumor Microenvironment and Immunotherapy: The Whole Picture Is Better Than a Glimpse
- (2015) Sarah E. Church et al. IMMUNITY
- Single-cell technologies are revolutionizing the approach to rare cells
- (2015) Valentina Proserpio et al. IMMUNOLOGY AND CELL BIOLOGY
- Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
- (2015) Stefano Ugel et al. JOURNAL OF CLINICAL INVESTIGATION
- Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group (E4697)
- (2015) David H. Lawson et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers
- (2015) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
- (2015) Naiyer A Rizvi et al. LANCET ONCOLOGY
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
- (2015) Thomas F. Gajewski SEMINARS IN ONCOLOGY
- Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy
- (2015) Helena Cirenajwis et al. Oncotarget
- Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
- (2015) Mihaela Angelova et al. GENOME BIOLOGY
- Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity
- (2015) Claire Germain et al. Frontiers in Immunology
- Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases
- (2015) Anna S Berghoff et al. OncoImmunology
- Immune monitoring technology primer: flow and mass cytometry
- (2015) Holden T. Maecker et al. Journal for ImmunoTherapy of Cancer
- Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
- (2015) Michael A. Postow et al. Journal for ImmunoTherapy of Cancer
- Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
- (2014) Claire Germain et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Single Slide Multiplex Assay for the Evaluation of Classical Hodgkin Lymphoma
- (2014) Denise Hollman-Hewgley et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
- (2014) L. Robert et al. CLINICAL CANCER RESEARCH
- Complexity and challenges in defining myeloid-derived suppressor cells
- (2014) Vera Damuzzo et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Functional Analysis via Standardized Whole-Blood Stimulation Systems Defines the Boundaries of a Healthy Immune Response to Complex Stimuli
- (2014) Darragh Duffy et al. IMMUNITY
- Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients
- (2014) Richard B. Kennedy et al. IMMUNOGENETICS
- Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines
- (2014) Inna G. Ovsyannikova et al. IMMUNOGENETICS
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays
- (2014) Heather E. Lynch et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab
- (2014) Ahmad A. Tarhini et al. PLoS One
- Intersection of population variation and autoimmunity genetics in human T cell activation
- (2014) C. J. Ye et al. SCIENCE
- Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients
- (2014) B. Mlecnik et al. Science Translational Medicine
- Improved Survival with T Cell Clonotype Stability After Anti-CTLA-4 Treatment in Cancer Patients
- (2014) E. Cha et al. Science Translational Medicine
- Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications
- (2014) C. Marcela Diaz-Montero et al. SEMINARS IN ONCOLOGY
- Dual roles for immune metagenes in breast cancer prognosis and therapy prediction
- (2014) Angela Alistar et al. Genome Medicine
- Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes
- (2014) S. Kitano et al. Cancer Immunology Research
- Antibody response to cancer/testis (CT) antigens: A prognostic marker in cancer patients
- (2014) Yoshihiro Ohue et al. OncoImmunology
- Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy
- (2014) Gautier Stoll et al. OncoImmunology
- Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes
- (2014) Lidia Robert et al. OncoImmunology
- Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
- (2013) Christiane Meyer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Genetic Variants Regulating Immune Cell Levels in Health and Disease
- (2013) Valeria Orrù et al. CELL
- Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor Types
- (2013) P. A. Ascierto et al. CLINICAL CANCER RESEARCH
- The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
- (2013) Jérôme Galon et al. IMMUNITY
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Functional polymorphisms ofTLR8are associated with hepatitis C virus infection
- (2013) Chiou-Huey Wang et al. IMMUNOLOGY
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
- (2013) Nienke van Rooij et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy
- (2013) Fernando Ulloa-Montoya et al. JOURNAL OF CLINICAL ONCOLOGY
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- Cytokine patterns in patients with cancer: a systematic review
- (2013) Bodo E Lippitz LANCET ONCOLOGY
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Dietary gluten triggers concomitant activation of CD4+ and CD8+ T cells and T cells in celiac disease
- (2013) A. Han et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MHC Class I-Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia
- (2013) M. Cobbold et al. Science Translational Medicine
- Genetic and Environmental Determinants of Human NK Cell Diversity Revealed by Mass Cytometry
- (2013) A. Horowitz et al. Science Translational Medicine
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations
- (2013) Berran Yucesoy et al. VACCINE
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis
- (2013) Srikanth Nagalla et al. GENOME BIOLOGY
- PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection
- (2013) A. W. MacFarlane et al. Cancer Immunology Research
- Intraindividual long term stability and response corridors of cytokines in healthy volunteers detected by a standardized whole-blood culture system for bed-side application
- (2012) Silke C Mueller et al. BMC Medical Research Methodology
- Higher numbers of T-bet+ intratumoral lymphoid cells correlate with better survival in gastric cancer
- (2012) Lu-jun Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
- (2012) T. Noguchi et al. CANCER RESEARCH
- The Immune Signature of CD8+CCR7+ T Cells in the Peripheral Circulation Associates with Disease Recurrence in Patients with HNSCC
- (2012) M. Czystowska et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
- (2012) D. S. Chen et al. CLINICAL CANCER RESEARCH
- A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin C as a Compatible Prognostic Marker in Human Solid Tumors
- (2012) M. Schmidt et al. CLINICAL CANCER RESEARCH
- CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
- (2012) J. S. Nielsen et al. CLINICAL CANCER RESEARCH
- Next generation sequencing for TCR repertoire profiling: Platform-specific features and correction algorithms
- (2012) Dmitry A. Bolotin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled Analysis
- (2012) Michail Ignatiadis et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloid-derived Suppressor Cells in Cancer Patients
- (2012) Alberto J. Montero et al. JOURNAL OF IMMUNOTHERAPY
- Cancer classification using the Immunoscore: a worldwide task force
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- The immune score as a new possible approach for the classification of cancer
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection
- (2012) Huabiao Chen et al. NATURE IMMUNOLOGY
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Associated Aberrant Protein O-Glycosylation Can Modify Antigen Processing and Immune Response
- (2012) Caroline B. Madsen et al. PLoS One
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- What are regulatory T cells (Treg) regulating in cancer and why?
- (2012) Theresa L. Whiteside SEMINARS IN CANCER BIOLOGY
- 12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?
- (2012) Jane L. Messina et al. Scientific Reports
- Tumor immunosurveillance in human cancers
- (2011) Bernhard Mlecnik et al. CANCER AND METASTASIS REVIEWS
- An immune-active tumor microenvironment favors clinical response to ipilimumab
- (2011) Rui-Ru Ji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
- (2011) Rachel F. Gabitass et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Characterization of Chemokines and Adhesion Molecules Associated with T cell Presence in Tertiary Lymphoid Structures in Human Lung Cancer
- (2011) L. de Chaisemartin et al. CANCER RESEARCH
- Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity
- (2011) Caroline Jochems et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
- (2011) Valerie Chew et al. GUT
- Function but not phenotype of melanoma peptide-specific CD8+ T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696)
- (2011) Carsten Schaefer et al. INTERNATIONAL JOURNAL OF CANCER
- Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
- (2011) Lukas Baitsch et al. JOURNAL OF CLINICAL INVESTIGATION
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures
- (2011) Thomas Karn et al. PLoS One
- Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
- (2011) J. Yuan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
- (2011) S. C. Bendall et al. SCIENCE
- Establishment of Antitumor Memory in Humans Using in Vitro-Educated CD8+ T Cells
- (2011) M. O. Butler et al. Science Translational Medicine
- Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules
- (2010) Andrew E Teschendorff et al. BMC CANCER
- Natural immunity to cancer in humans
- (2010) Gabriela Bindea et al. CURRENT OPINION IN IMMUNOLOGY
- Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor–Positive and –Negative Cancers
- (2010) Giampaolo Bianchini et al. JOURNAL OF CLINICAL ONCOLOGY
- Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells
- (2010) Takashi Inozume et al. JOURNAL OF IMMUNOTHERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Seromic profiling of ovarian and pancreatic cancer
- (2010) S. Gnjatic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comprehensive assessment of T-cell receptor -chain diversity in T cells
- (2009) H. S. Robins et al. BLOOD
- Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
- (2009) M. Ahmadzadeh et al. BLOOD
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/- Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN- 2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
- (2009) J. M. Kirkwood et al. CLINICAL CANCER RESEARCH
- Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer
- (2009) Bernhard Mlecnik et al. GASTROENTEROLOGY
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
- (2009) Franck Pagès et al. JOURNAL OF CLINICAL ONCOLOGY
- Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients
- (2009) Valerie Chew et al. JOURNAL OF HEPATOLOGY
- Autoimmune Antibodies and Recurrence-Free Interval in Melanoma Patients Treated With Adjuvant Interferon
- (2009) Marna G. Bouwhuis et al. JNCI-Journal of the National Cancer Institute
- CXCL10 expression and prognostic significance in stage II and III colorectal cancer
- (2009) Zheng Jiang et al. MOLECULAR BIOLOGY REPORTS
- Immune infiltration in human tumors: a prognostic factor that should not be ignored
- (2009) F Pagès et al. ONCOGENE
- The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
- (2008) M. Schmidt et al. CANCER RESEARCH
- Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures
- (2008) Marie-Caroline Dieu-Nosjean et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of Serum S100B Protein in High-Risk Surgically Resected Melanoma Patients Participating in Intergroup Trial ECOG 1694
- (2008) Ahmad A. Tarhini et al. JOURNAL OF CLINICAL ONCOLOGY
- Humoral Immunity Directed against Tumor-Associated Antigens As Potential Biomarkers for the Early Diagnosis of Cancer
- (2008) Hailing Lu et al. JOURNAL OF PROTEOME RESEARCH
- Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer
- (2008) J. S. Ross et al. ONCOLOGIST
- CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
- (2008) J. Yuan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CTLA-4 blockade increases IFN -producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients
- (2008) C. I. Liakou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started